PULM – pulmatrix, inc. (US:NASDAQ)
Stock Stats
News
3/26
08:17 am
pulm
Medium
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan [Yahoo! Finance]
3/26
08:00 am
pulm
High
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
3/2
08:22 am
pulm
High
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities [Yahoo! Finance]
3/2
08:00 am
pulm
High
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
2/26
08:19 am
pulm
High
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results [Yahoo! Finance]
3/27
05:16 pm
pulm
Neutral
Form 8-K Pulmatrix, Inc. For: Mar 26
3/26
09:12 am
pulm
Medium
Form 425 Pulmatrix, Inc. Filed by: Pulmatrix, Inc.
3/2
08:01 am
pulm
High
Form 8-K Pulmatrix, Inc. For: Feb 28
2/26
08:21 am
pulm
High
Form 10-K Pulmatrix, Inc. For: Dec 31
2/26
08:06 am
pulm
High
Form 8-K Pulmatrix, Inc. For: Feb 26
Show more
Top News Gainers
1/2 Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson 86.2%
4/1 Pulmatrix Inc (NASDAQ: PULM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 24.3%
4/15 Form 8-K Pulmatrix, Inc. For: Apr 09 9.9%
8/22 Form 8-K Pulmatrix, Inc. For: Aug 22 8.1%
4/24 Form D Pulmatrix, Inc. 8.0%
1/6 Pulmatrix Announces Research Collaboration with Nocion Therapeutics to Explore Inhaled Drug Delivery Technologies 7.4%
11/19 Form 8-K Pulmatrix, Inc. For: Nov 19 7.3%
4/29 Form DEF 14A Pulmatrix, Inc. For: Jun 17 6.6%
10/30 Form 8-K Pulmatrix, Inc. For: Oct 25 5.5%
11/18 Form 8-K Pulmatrix, Inc. For: Nov 13 4.9%
Top News Decliners
4/16 Pulmatrix Announces $8.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -28.6%
3/26 Form 10-K Pulmatrix, Inc. For: Dec 31 -15.7%
1/30 Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA -12.9%
4/16 Pulmatrix and Sensory Cloud Announce Partnership to Develop and Commercialize a Potential Nasal Prophylactic and Anticontagion Product for COVID-19 -10.2%
4/24 Form SC 13G Pulmatrix, Inc. Filed by: ARMISTICE CAPITAL, LLC -7.7%
8/19 Pulmatrix Receives US Patent Covering iSPERSE™ Formulations for Pulmazole Program -6.7%
3/9 Pulmatrix Inc (NASDAQ: PULM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.5%
11/1 Q3/2019 9/30/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A -6.5%
2/11 Form SC 13G/A Pulmatrix, Inc. Filed by: INTRACOASTAL CAPITAL, LLC -6.0%
11/14 Pulmatrix Inc (NASDAQ: PULM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock. -5.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3